Nuvalent, Inc. — Director's Dealing 2021

Jul 29, 2021

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Nuvalent, Inc. (NUVL)
CIK: 0001861560
Period of Report: 2021-07-28

Reporting Person: Wellington Biomedical Innovation Master Investors (Cayman) I L.P. (10% Owner)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Series B Preferred Stock	$		Class A Common Stock (897671)		Direct

Footnotes

F1: Each share of Series B Preferred Stock is convertible into 0.1858 shares of the Issuer's Class A Common Stock at any time at the holder's election. Upon the closing of the Issuer's initial public offering, all such shares of Series B Preferred Stock will automatically convert into the number of shares of Class A Common Stock of the Issuer shown in column 3. The Series B Preferred Stock has no expiration date.